Podcasts about dcis

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter explores the critical topic of breast cancer screening, examining why thousands of women continue to die from breast cancer each year despite the availability of effective screening tools. He explains the strengths and limitations of current screening strategies, reviews the recommendations from major medical organizations, and discusses why screening guidance can often seem confusing or contradictory. Peter outlines a practical framework for understanding breast cancer risk and personalizing screening decisions, including when to begin screening, how frequently to screen, and which imaging modalities may be most appropriate based on an individual's risk profile. Throughout the episode, he emphasizes that while population-based guidelines provide an important foundation, optimizing outcomes requires a more personalized approach aimed at helping women make informed screening decisions that can improve the chances of early detection and successful treatment. We discuss: Why women still die from breast cancer: the benefits of screening, the problem of under-screening, and the need for risk-based screening strategies [1:45]; Current screening recommendations, why they differ between organizations, and the importance of personalized screening decisions [6:30]; A framework for personalizing screening [8:45]; Assessing baseline breast cancer risk: genetics, family history, breast density, lifestyle factors, and the role of risk calculators in personalized screening [9:30]; Balancing cancer detection and false positives: how breast cancer risk influences screening intensity and imaging choices [17:45]; Mammography as the foundation of breast cancer screening: detecting ductal carcinoma in situ (DCIS) and the advantages of 3D versus 2D mammography [21:00]; MRI for high-risk women: the benefits of supplemental screening, abbreviated MRI, and the emerging role of contrast-enhanced mammography [23:00]; The role of ultrasound: supplemental cancer detection, diagnostic evaluation, and limitations compared with mammography and MRI [26:00]; Choosing the right breast cancer screening strategy: imaging modality selection, screening hierarchies, and the importance of imaging center quality [28:00]; How often should you screen for breast cancer? [30:15]; At what age should you start screening? [37:30]; Breast cancer in younger women: aggressive tumor biology, BRCA-related risk, breast density, and individualized decisions about when to begin screening [41:45]; Inflammatory breast cancer, the limitations of screening mammography for symptomatic disease, and the importance of promptly evaluating new breast symptoms in both women and men [44:45]; From risk assessment to personalized screening: a practical framework for reducing breast cancer mortality through earlier and more effective detection [46:30]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

In this episode, we review the high-yield topic of ⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠Ductal Carcinoma In Situ (DCIS) from the Oncology section at ⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

JCO Editorial Fellow Dr. Yuvanesh Vedaraju and JCO Associate Editor Dr. Kathy Miller discuss the ASCO 2026 Simultaneous Publication paper "Low-Dose Tamoxifen in Non-Invasive Breast Neoplasia: Long-Term Results from an Individual Participant Data Pooled Analysis." LINK TO FULL TRANSCRIPT  

General Principles and Triple AssessmentThe foundation of breast cancer diagnosis is the Triple Assessment protocol, which includes clinical examination, imaging, and pathological assessment.Diagnostic accuracy reaches 99.9% when all three modalities of the Triple Assessment align.Imaging choices are age-dependent, with ultrasound preferred for women under 35 and mammography for those over 35.Core needle biopsy is superior to fine-needle aspiration because it differentiates between in situ and invasive disease and allows for hormone receptor and HER2 status testing.The majority of breast cancers are sporadic, accounting for 65% to 75% of cases, while hereditary factors like BRCA 1 and 2 mutations contribute to 5% to 10%.Classification and Clinical PresentationBreast cancer is classified into non-invasive types, such as Ductal Carcinoma In Situ (DCIS), and invasive types, of which invasive ductal carcinoma is the most common.The most frequent clinical presentation is a hard, irregular, non-tender, and poorly mobile palpable mass.Approximately 60% of breast tumors are located in the upper outer quadrant.Advanced clinical features include skin dimpling from Cooper's ligament involvement, nipple retraction, and peau d'orange due to lymphatic obstruction.Paget's disease of the nipple presents as a unilateral, eczema-like ulceration and is often associated with an underlying malignancy.Staging and PrognosisClinical staging follows the TNM system, assessing the primary tumor size (T), regional lymph node involvement (N), and distant metastasis (M).Stage I and II are classified as early breast cancer, Stage III as locally advanced, and Stage IV as metastatic disease.The Nottingham Prognostic Index (NPI) calculates prognosis based on tumor size, nodal status, and histological grade.Five-year survival rates decrease significantly with advancing stage, from 90% in Stage I to 20% in Stage IV.Management of DCIS and Early Breast Cancer (Stages I & II)DCIS is a non-invasive cancer confined by an intact basement membrane that requires treatment to prevent progression to invasive disease.Standard treatment for DCIS is breast-conserving surgery (BCS) followed by radiation, or a mastectomy if the disease is widespread.For early invasive cancer, BCS followed by radiation is oncologically equivalent to a total mastectomy.Sentinel lymph node biopsy (SLNB) is the standard for staging the axilla in clinically node-negative patients to avoid the morbidity of full axillary dissection.Adjuvant systemic therapy, including endocrine therapy for ER-positive tumors and anti-HER2 therapy for HER2-positive tumors, is dictated by the tumor's biological profile.Management of Locally Advanced (Stage III) and Metastatic Cancer (Stage IV)Locally advanced breast cancer is treated with neoadjuvant systemic therapy as the first step to shrink the tumor and treat micrometastatic disease before surgery.Following neoadjuvant therapy, axillary lymph node dissection is mandatory if nodes were positive at presentation, regardless of the clinical response.Post-mastectomy radiation is indicated for tumors larger than 5 cm or when four or more axillary nodes are positive.Metastatic (Stage IV) disease is treatable but generally incurable, focusing on palliation and maintaining quality of life.Systemic therapy is the mainstay for Stage IV, and routine surgery on the primary tumor is avoided unless needed for local symptom control.Bone is the most common site of metastasis, requiring management with bone-modifying agents like bisphosphonates to prevent skeletal complicatio

Lifestyle Medicine & Breast Cancer: Prevention, Treatment Support & Recovery What actually impacts cancer risk—and what helps you get through it? This episode blends expert insight and lived experience to reveal how lifestyle medicine supports prevention, treatment, and healing. In this episode of Her Health Compass, we explore what it truly means to heal through the lenses of resilience, grief, and lifestyle medicine. Yonni and Heather are joined by Dr. Amy Comander, a breast cancer specialist trained in lifestyle medicine, and Britt Aronson, who shares her powerful firsthand experience navigating cancer alongside profound personal loss. Together, they unpack how nutrition, movement, sleep, stress, and mindset can influence not only cancer prevention, but also treatment outcomes and recovery. This conversation bridges science and story—offering both evidence-based insight and lived experience for anyone seeking to better understand their body, their health, and their capacity to heal. Amy Comander, MD, DipABLM, FACLM, MSCP is a breast oncologist and Medical Director of the Mass General Brigham Cancer Institute in Waltham, Director of the Lifestyle Medicine Program at the Mass General Brigham Cancer Institute, and an instructor in medicine at Harvard Medical School. Dr. Comander developed a passion for understanding the biological basis of behavior, and she studied neurobiology and psychology as part of the multidisciplinary Mind, Brain, and Behavior Initiative at Harvard University. She then received her Doctor of Medicine from the Yale University School of Medicine. She completed her internal medicine residency training and Hematology-Oncology fellowship training at Beth Israel Deaconess Medical Center and Harvard Medical School. She is board-certified in internal medicine, hematology, medical oncology, and Lifestyle Medicine. As a breast oncologist, Dr. Comander has witnessed the struggles her patients face during and following completion of primary cancer treatment, and is passionate about improving the overall health and well-being of breast cancer survivors through lifestyle interventions.  In collaboration with Dr. Frates, she launched the PAVING the Path to Wellness Program lifestyle medicine program for breast cancer survivors. She trains other colleagues to run PAVING groups, so that this transformational experience can be offered to a larger group of  cancer survivors.   She has co-authored PAVING Your Path Through Breast Cancer and Beyond,  PAVING the Path to Wellness Manual and Workbook, and PAVING a Path Through Menopause and Beyond. Dr. Comander practices what she preaches, having run marathons, including 12 consecutive Boston Marathons to date, with the goal to improve the lives of those with a diagnosis of cancer.   Dr. Comander was honored to serve as the first oncologist on the Board of Directors of the American College of Lifestyle Medicine. She is proud to serve as Vice President on the Board of the PAVING the Path to Wellness non-profit organization.  She also serves on the Board of the Ellie Fund, a non-profit that provides services and support to women diagnosed with breast cancer in Massachusetts. She is a medical advisor to the non-profit organizations, SurvivingBreastCancer.org and the Tigerlily Foundation.   She has served as a medical advisor to Oneinforty, a non-profit organization dedicated to educating people of Ashkenazi Jewish heritage about the one-in-forty chance of having inherited a BRCA mutation.   Britt Aaronson is a freelance writer and editor based in Los Angeles, where she has lived since 1993. She finds great joy in being a mother to Rayce and Eisley. In her free time, she enjoys yoga, hiking, traveling, and supporting nonprofits including the National Brain Tumor Society, the Hidden Hills Theater Committee, and the Fondle Project. In February 2020, she was diagnosed with Grade 2–3 DCIS breast cancer. Britt underwent seven surgeries—including a double mastectomy, reconstruction, and capsulectomies—and is grateful to now be cancer-free. Deeply appreciative of the technology that led to her diagnosis, she is dedicated to raising awareness and helping redefine conversations around breast health, survivorship, and healing. Find Yonni & Heather here https://www.herhealthcompass.com/

Melissa Mariano is a 43-year-old Canadian flight attendant living in Dubai who was diagnosed with triple positive (ER+, PR+, HER2+) breast cancer after a routine mammogram...zero symptoms, zero lumps. She almost skipped her follow-up appointment. In this episode, she shares how she went from stage 0 DCIS to navigating Herceptin without chemo, low-dose "Baby Tam," the Dutch test, and a radical people-pleasing wake-up call that changed everything. In this episode we cover: How calcifications on a mammogram went from "nothing to worry about" to a biopsy — and why she delayed 4 months The vacuum-assisted biopsy that may have removed her invasive cancer entirely before surgery even happened Why her final pathology came back DCIS only, stage 0 — and what triple positive actually means 18 rounds of Herceptin (anti-HER2) with NO chemo — and the NCCN guideline that made that possible The Italian Clancy study on "Baby Tam" (5mg Tamoxifen) and why she's tapering down from 20mg Dutch test results: high estrogen, good methylation — what it means and what she's doing about it Supplements she's using: L-theanine, Relora, liposomal glutathione, DIM (cycled), NAC Sauna 2x/week, red light therapy, hyperbaric oxygen, yin yoga, sound healing, Reiki, breathwork — her full protocol Egg freezing for fertility preservation before starting Tamoxifen The people-pleasing pattern she believes contributed to her diagnosis — and the shift that changed everything Why she says: "I'm no longer a phony — but I am my priority" Links & Resources: Clancy Study on Low-Dose Tamoxifen (Baby Tam / 5mg): READ HERE NCCN Guidelines for Breast Cancer: READ HERE Connect with Melissa Mariano: https://www.instagram.com/melidubai/ Not Today Cancer Inner Circle (weekly live calls, community support): [INFO HERE] BrocElite: 20% off here Chapter Markers (estimated) 00:00 — Intro: Meet Melissa — Dubai life, flight attendant, Italian roots 04:00 — The mammogram that almost didn't happen: calcifications and a delayed follow-up 08:30 — Biopsy results: triple positive, Grade 2 IDC + high-grade DCIS 13:00 — MRI showed no mass enhancement — the biopsy may have removed the cancer 19:00 — Surgery, clear margins, final pathology: stage 0 DCIS 22:00 — 20 rounds radiation — spinning and yoga the whole way through 25:00 — Herceptin without chemo: the NCCN guideline that changed everything 28:00 — Tamoxifen side effects, Baby Tam, and the Italian Clancy study 34:00 — Dutch test results, functional gynecologist Dr. Maria, supplement protocol 38:00 — Sauna, red light, hyperbaric oxygen, yin yoga, sound healing 44:00 — "I'm no longer a phony — but I am my priority": the people-pleasing shift 50:00 — What cancer gave her: resilience, perspective, advocacy 54:00 — Closing: the "Nope. Not Today." shirt moment + not today cancer Medical disclaimer: This episode is for informational and educational purposes only and is not intended as medical advice. Always consult your own oncologist, physician, or qualified healthcare provider before making any decisions about your diagnosis, treatment, or supplement protocol.

In this solo episode, Dr. Jenn Simmons delivers a five-alarm wake-up call on breast cancer screening. The American College of Physicians just dropped new guidelines and the radiology world is furious, not because the science is wrong, but because it isn't on their side. Dr. Jenn breaks down what the data actually shows, why mammography's survival benefit has been a statistical illusion for decades, and what real preventive screening looks like.She also takes on DCIS, collagen fears, and the question every woman with a breast cancer history is afraid to ask about hormones. Every woman deserves this information before she makes a decision, not after.What You'll LearnWhy DCIS is not breast cancer and what the data says about over treating itWhat the new ACP mammography screening guidelines say and why the radiology world responded with opinion instead of evidenceHow lead time bias and over diagnosis have made mammography look like a lifesaver when it isn'tWhat the Wisdom Trial revealed about personalized breast cancer screening and why the results make annual mammogram guidelines indefensibleWhat preventive breast cancer screening actually looks like without radiation, compression, or harmWhy collagen supplementation has no association with breast cancer risk or recurrenceWhy bioidentical hormone replacement therapy is not off the table after a breast cancer diagnosis.Why you need to tread the root cause and treat the tumorTo talk to a member of Dr. Jenn's team and learn more about working privately with Dr. Jenn visit: https://calendly.com/stephanie-1031/clarity-callTo get your copy of Dr. Jenn's book, The Smart Woman's Guide to Breast Cancer, visit: https://tinyurl.com/SmartWomansBreastCancerGuideTo purchase the auria breast cancer screening test go here https://auria.care/ and use the code DRJENN20 for 20% Off.Connect with Dr. Jenn:Website: https://www.jennsimmonsmd.com/Facebook: https://www.facebook.com/DrJennSimmonsInstagram: https://www.instagram.com/drjennsimmons/YouTube: https://www.youtube.com/@dr.jennsimmons

A patient advocate/cancer survivor and a healthcare professional discuss key topics including early breast cancer diagnosis, role of self-agency in pursuing optimal cancer care, encouraging trial participation with patient testimonials, and other considerations for the patient care journey such as appropriate screening, follow-up encounters for questions, guideline-based treatments, and side effect management.  Participants Kristen D. Whitaker, MD, MS Breast Medical Oncologist Medstar Georgetown Center Institute at Washington Hospital Center Assistant Professor of Medicine Georgetown University School of Medicine Washington, DC Asha Miller Founder, Asha Miller Creative Patient Advocate and Consultant Patient Experience and Health Equity Breast Cancer Veteran Columbus, Ohio Link to full program:https://bit.ly/47XIKV7 Get access to all our new podcasts by subscribing to the Decera Clinical Education Oncology Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Diagnosed with DCIS while underinsured and between jobs, Ayanna Wilcher found compassionate biopsy care at The Rose and chose her own path through mastectomy and multiple opinions. Now, she leads survivor work and Rising in Grace, delivering post mastectomy comfort kits and community. Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts. Key Questions Answered 1. How Ayanna’s life and work shifted in the year leading up to her diagnosis, including job loss and a move back into higher education. 2. How she first felt a lump, what her recent mammogram history was, and which steps her doctor friend urged her to take. 3. What it was like to be underinsured when a biopsy was recommended and how she was referred to The Rose for care. 4. How Ayanna experienced her biopsy at The Rose, including the provider’s communication, pain control, and overall respect. 5. What happened the day she received her cancer diagnosis while traveling, and how she coped emotionally during her conference responsibilities. 6. Why she and her team named the cancer “Beulah” and how humor and mindset helped her face decisions about surgery. 7. How insurance battles over imaging, multiple oncology opinions, and differing chemo recommendations led her to choose a non chemo maintenance path with Texas Oncology. 8. How her husband’s decision to take a lower paying out of state job for health insurance, and her children’s responses, shaped the family’s experience of her cancer. 9. What specific challenges women face after mastectomy, from drains and lack of rest to the cost of pillows, bras, and other comfort items. 10. How Rising in Grace and Ayanna’s work with Angels Surviving Cancer and patient navigation training aim to make post mastectomy life less isolating and more supported. Timestamped Overview 00:00 Introduction, background, and 2026 as a rebuild year02:00 Clean mammogram, new lump, and fast follow up03:30 Job loss, underinsurance, and biopsy denial03:45 Referral to The Rose and compassionate biopsy experience05:00 DCIS diagnosis on a flight and initial shock06:30 Humor, naming “Beulah,” and building a care plan07:50 Meeting oncology team and facing mastectomy decision09:30 Moomoo mastectomy party and surgery day12:30 Pathology results, nine invasive sites, and chemo debate13:40 Second and third opinions, choosing no chemo, “bet on yourself”15:15 Impact on husband, children, and mother; caregiver burden20:00 Angels Surviving Cancer, patient navigator training, leadership21:30 Launching Rising in Grace and creating post mastectomy kits23:30 Realities of drains, rest, and the cost of comfort items26:00 Body image, bras, and emotional recovery after mastectomy29:00 Final message: act early, seek support, and remember it is not the endSee omnystudio.com/listener for privacy information.

In this episode of SurgOnc Today®, Drs. Bonci, Boughey & Adesoye review the most important breast cancer management updates from the 2025 San Antonio Breast Cancer Symposium. Expert breast surgical oncologists discuss new findings on axillary surgery and when less invasive approaches may be safely considered, the role and impact of preoperative MRI in newly diagnosed breast cancer cases, and emerging strategies for the non-surgical management of DCIS. This episode focuses on what surgeons need to know now - and how these studies may guide patient care moving forward.

In this week's episode of the We Didn't Plan For This series, Nora and Adrienne explore how sometimes life doesn't slowly change — sometimes it changes in an instant.Nora has done everything right. She took care of her health, exercised, ate well, and paid attention to her body — and she still got breast cancer.She shares the reality of diagnosis, biopsies, MRIs, and preparing for a double mastectomy and reconstructive surgery, along with the uncomfortable and often humiliating parts of female healthcare, and how breath work became the one thing she could control when everything else felt uncertain.From her time in the Air Force and deployment during Iraqi Freedom to the impact of burn pits, Nora reflects on how strength changes over time and what resilience actually means. She shares how breath, mindset, and her community are helping her get through one of the hardest seasons of her life.This episode is about awareness, about using hard things as fuel to help others, and about learning to control the things you can control — especially your breath.If you're listening to this in your car, take a moment before you get out, pause, and take one breath.Send us Fan MailWanna be on the show? Click here to fill out our guest info form or drop us a email at yogachanged@gmail.comFollow us on TikTok:https://www.tiktok.com/@yogachangedFollow us on Instagram:https://www.instagram.com/yogachanged/For more, go to https://howyogachangedmylife.comThe theme music for this episode, “Cenote Angelita”, was written and produced by Mar Abajo Rio AKA MAR Yoga Music. Dive deeper into this and other original yoga-inspired compositions by visiting bio.site/mcrworks. For the latest updates on upcoming events featuring his live music for yoga and meditation, be sure to follow @maryogamusic on Instagram. 

Nancy and Shelley didn’t plan to share a breast cancer story, much less two very different diagnoses, eight years apart. One faced Stage 0 DCIS at 41 after pushing for a 3D mammogram; the other walked into an annual screening, felt no lump, and still heard “Stage 2 HER2‑Positive.” In this conversation, we talk about what happens when two pragmatic, organized women lean on faith, friendship, and their networks to move fast on treatment—then turn around and use their experience to champion The Rose and the women who rely on us for access to mammograms, diagnostics, and compassionate care. Please consider sharing this episode, or making a donation at therose.org so more women receive breast cancer screening and care. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts. Key questions answered How did Nancy and Shelley each grow up with service and volunteering, and how did that shape their careers and philanthropy? What kind of work do they do in the plastics industry, and how did Shelley end up co‑inventing a “tiltless” liner used around the world? How did Shelley’s first 3D mammogram at 41 lead to a stage zero DCIS diagnosis, and why did she struggle to call it “cancer”? What made Nancy’s diagnosis different—stage two HER2‑positive with no lump—and how did prior research for Shelly help her move quickly? How did Nancy’s long history of volunteering and relationships at Baylor help both mother and daughter fast‑track appointments and treatment? What do they mean by “God winks,” and how did shared surgeons, the same radiologist, and overlapping timelines reinforce their faith? In what ways did cancer deepen—rather than define—their mother–daughter relationship and cement that “best friends” dynamic? How do they each use their stories now to push friends, colleagues, and even their kids to prioritize mammograms and routine screenings? Why is The Rose the organization they chose to champion, and how do insured patients’ mammograms help cover care for uninsured and underinsured women? What do they want listeners to understand about the emotional side of bell‑ringing, being present for each other, and never being “too busy” to schedule preventive care? Timestamped overview 03:20 Welcoming Nancy and Shelley as Everything’s Coming Up Roses honorees; their shared background as successful women in male‑dominated plastics and lifelong volunteers. 07:20 Nancy’s early volunteer roots, decades with arts and civic groups, current work with the Greater Houston Women’s Chamber of Commerce, and Shelley’s career in plastics—including her patented tiltless liner and global travel as a family. 10:00 The “backwards” breast cancer story: Shelley’s stage zero DCIS diagnosis at 41 after pushing for a 3D mammogram, her embarrassment about calling it cancer, and the lack of family history aside from an elderly grandmother. 14:30 Nancy’s 2023 diagnosis: annual mammogram, no lump, stage two HER2‑positive, choosing a world‑class oncologist, and how watching Shelley’s calm, research‑driven approach prepared her. 18:30 How Nancy’s Baylor relationships and volunteer network helped both women move quickly through diagnosis and into treatment; the shared focus on reducing the stress of “waiting” and the role of faith in that season. 22:30 “God winks”: both having the same surgeon, Shelley’s husband later sharing her radiologist, and the reminder that—even for highly organized women—God is still in control. 26:30 How their faith kept them from seeing cancer as punishment, why they refused to play the victim, and how the experience tightened their bond without defining their identities. 31:10 Bell‑ringing surprises: Nancy showing up for Shelley’s bell, Shelley returning the favor and scaring her mom in the parking lot, and how those moments became treasured markers in their journey. 32:44 Using their platform: encouraging others to schedule mammograms, explaining how insured patients at The Rose help fund care for uninsured women, and embracing their “backwards” mother–daughter honoree role to amplify The Rose’s mission and make sure no woman walks around not knowing help is available.See omnystudio.com/listener for privacy information.

Shelley didn’t see herself as “an honoree.” She saw herself as a working mom in a male‑dominated industry who just wanted to stay ahead of breast cancer. In this conversation, she walks us through the mammogram she almost didn’t get, receiving the news of a Stage 0 DCIS diagnosis, and the 10 years of follow‑up, skin checks, and colonoscopies that followed. Her story reminds us that early detection, asking questions, and having access to care—like the care The Rose offers uninsured and underinsured women—can change everything. She also shares why she’s using her role at this year's Everything’s Coming Up Roses Luncheon to spotlight access to mammograms and diagnostics for women who can’t afford them. Please consider sharing this episode, or making a donation at therose.org so more women receive breast cancer screening and care. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts. Key Questions Answered What led Shelley to push for her first 3D mammogram at 41 instead of waiting until 50? How did her history—friends with breast cancer in their 30s and a family member who died—shape her sense of urgency? What does a stage zero DCIS diagnosis mean, and why did she wrestle with whether it “counted” as breast cancer? How did Shelley decide on a shorter, more intense “Canadian” radiation regimen, and what side effects did she experience? How did she talk to her husband and young son about her diagnosis without overwhelming them? In what ways did her workplace support her through biopsy, lumpectomy, and radiation so she could keep working? How did ringing the bell—and seeing her mother there—change how she processed the whole experience emotionally? Why did she become more assertive with doctors about mammograms, Pap smears, and other screenings after cancer? How did later health scares—melanoma on her back and her husband’s colon cancer—reinforce her commitment to early detection? What does Shelley hope listeners understand about The Rose’s role in providing mammograms, diagnostics, and treatment navigation for uninsured and underinsured women? Timestamped overview 03:30 Honoree at Everything’s Coming Up Roses, Shelley’s background as a mom and plastics industry leader, and her mother’s role as a business owner. 07:30 Pushing for an early mammogram at almost 40, getting delayed, then insisting at 41 on a 3D mammogram because of friends and family lost to breast cancer. 10:00 Calcifications, biopsy, lumpectomy, and hearing “stage zero DCIS”; becoming a “Google doctor” and wrestling with whether stage zero “counts” as cancer. 14:30 Choosing a four‑week Canadian radiation regimen, handling side effects, staying organized with questions for every doctor, and finishing treatment. 18:30 Ringing the bell, being surprised by her mom, finally breaking down, and how her kids processed “Mommy is sick but getting treated.” 22:30 Work support, flexible leave, staying on the job through treatment, and the relief of not having to fight employers while fighting cancer. 26:00 Living as a pragmatic, matter‑of‑fact patient, annual anxiety around scans, pushing for Pap smears and colonoscopies, and learning to question doctors. 29:00 Melanoma diagnosis, yearly (now more frequent) skin checks, taking her kids for annual skin exams, and teaching them why preventative care matters. 30:16 Her husband’s colon cancer, why “cancer” is both a scary and hopeful word in their home, and what it means to step into the honoree role to support The Rose’s mission of early detection and access to care for women who can’t afford it.See omnystudio.com/listener for privacy information.

Love the episode? Send us a text!When Breast Cancer Changes Everything — What Do You Build Next?What happens when a breast cancer diagnosis strips away your identity — and forces you to rebuild from the inside out?In this deeply personal and powerful episode of Breast Cancer Conversations, Laura Carfang sits down with Christine Handy and Christine Anastos — two breast cancer survivors who turned trauma into transformation.Christine Handy, former international model and author of Walk Beside Me, opens up about:Undergoing multiple mastectomy surgeriesBreast implant illnessReturning to the runway as a “breastless model”Turning her book into the award-winning film Hello BeautifulReclaiming worth beyond appearanceChristine Anastos (christine@connect-and-thrive.com), environmental engineer and founder of Connect & Thrive (CAT)  shares:Being diagnosed with DCIS while caregiving for her motherCancer's financial toxicity and hidden barriersWhy 90% of breast cancer cases may be environmentally influencedLaunching a public benefit corporation to bridge gaps in survivorship careTogether, these women explore:Identity after a cancer diagnosisFaith and post-traumatic growthThe myth of “doing it alone”Why collaboration is more powerful than competitionWhat it really means to be a “cancer disruptor”Welcome to the conversation. Support the showLatest News: Become a Breast Cancer Conversations+ Member! Sign Up Now. Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources! Enjoying our content? Please consider supporting our work.

It's one of the biggest news weeks of the year as ComicsPRO explodes with announcements, reveals, and long-term publishing plans from every major publisher in the industry. We're breaking it all down in a super-sized news segment that covers the headlines shaping 2026 and beyond. Marvel dropped its May 2026 solicitations, teased the beginning of the end in Avengers: Armageddon, confirmed Hulk War for 2027, revealed Infernal Hulk vs. the X-Men, and somehow still found time for Knull vs. Hela, a Spider-Man and Iron Man team-up, and Doctor Doom taking over OREO. Yes, really. Visit our Patreon page to see the various tiers you can sign up for today to get in on the ground floor of AIPT Patreon. We hope to see you chatting with us on our Discord soon! NEWS Marvel Solicitations May 2026 Infernal Hulk declares war on the X-Men in explosive issue #7 reveal - EXCLUSIVE Marvel reveals a Spider-Man and Iron Man team up coming in issue #6 Marvel teases “With Great Power…” as “Armageddon Assembles” this June Ultron crashes Wiccan and Hulkling's anniversary in Marvel's explosive Pride special Marvel teases 'The origin of the end' starts in 'Avengers: Armageddon' #1 It's Knull vs. Hela in 'Hel on Earth' Marvel Comics event JULY: Queen in Black! Doctor Doom takes over OREO in wild final Marvel Comics cookie collab Marvel announces new series 'X-Men: Outback' revisiting the iconic Outback Era Hulk War is coming: Marvel confirms Infernal Hulk finale in 2027 IDW is taking Godzilla back to 1954 and making it absolutely terrifying 'Star Trek' #1 launches a bold new era as IDW unveils massive 60th anniversary comic plans 'TMNT' #300 unleashes a massive new era, blind bag covers, and new 'Last Ronin' DC Solicits May 2026 DC Is going all-in on 'The Dark Knight Returns' for its 40th anniversary all year long DC and Sonic reunite for ‘Metal Legion' this May 2026 DC unveils major 2026 publishing plans at ComicsPro: Vertigo, new Absolute titles, and more Zorro and Tarzan are storming back to comics and we've got the exclusive first look Gail Simone is entering the Spawn universe with a brutal new 'She-Spawn' series New Image sci-fi series 'If Destruction Be Our Lot' features robo Abraham Lincoln finding purpose Skybound announces ‘DC Silver Age Covers and Stories' Artist Edition M.A.S.K. joins the Energon Universe in explosive new series from Dan Watters and Pye Parr Robert Kirkman returns to superheroes with 'Terminal' joined by Kubert, Finch, and Arthur Adams James Tynion IV takes on white supremacy and Norse gods in brutal new 9-part horror, 'Odin' 'The Cutting Garden' explores companionship, legacy, and sacrifice Ghost Machine just revealed 'The Unbelievables' and its first massive crossover EXCLUSIVE: Zack Kaplan unleashes three new Dark Horse series in 2026 Skateboarding is outlawed in new series 'Skate Ali' out June 2026 Jonathan Hickman's ‘Three Worlds/Three Moons' comes to Dark Horse this July Archie is going compact with new Oni Press collections starting in September 2026 'Ben 10' returns to comics this May with a new series from the original creators Oni Press unleashes 'Super Mondo Mega Mutts' #1 this July Oni Press announces Joe Palmer's dystopian thriller 'Destination Kill' #1 Our Top Books of the Week: Dave: Absolute Batman #17  (Scott Snyder, Eric Canete) Uncanny X-Men #24 (Gail Simone, David Marquez) Alex:​​ Exquisite Corpses #10 (Jordie Bellaire, Marianna Ignazzi) Dungeons of Doom #2 (PHILLIP KENNEDY JOHNSON & BENJAMIN PERCY) Standout KAPOW moment of the week: Alex: Uncanny X-Men #24 (Gail Simone, David Marquez) Dave: Ultimate Spider-Man #24 (March Checchetto, Hickman) TOP BOOKS FOR NEXT WEEK Alex: Infernal Hulk #4 (Phillip KJ, Nic Klein) & Absolute Wonder Woman #17 (K Thompson, H Sherman) Dave: The Peril of the Brutal Dark #1 (Chris Condon, Jacob Phillips) but also Hulk Smash Everything #3 JUDGING BY THE COVER JR. Dave: Predator: Bloodshed #1 (Dan Panosian Virgin Cover) Alex: Power Fantasy #16 (Morgan Beem variant)

Jamie sits down with Jennifer Herrod, a breast nurse navigator with nonprofit Project 31 and a seven-year breast cancer survivor, to talk about early detection, self-advocacy, and the power of community.Jennifer shares her diagnosis of DCIS (grade 3) at age 43, her treatment journey including mastectomy with immediate reconstruction, and why learning your “normal” and speaking up about breast changes, no matter your age, can make all the difference. She also explains how Project 31 supports and their podcast, Pink Ribbon Rollercoaster supports survivors and families through peer support, mentoring, education, and survivorship resources, reminding listeners that healing doesn't stop when treatment ends.Project 31 on InstagramProject 31 on FacebookProject 31 on LinkedIn

Love the episode? Send us a text!What happens when a breast surgeon becomes a breast cancer patient—and then faces a second diagnosis years later?In this deeply personal and illuminating episode of Breast Cancer Conversations, host Laura Carfang is joined by Dr. Anne Peled, a board-certified breast, reconstructive, and plastic surgeon who has treated thousands of patients—and also navigated her own early-stage breast cancer diagnosis, followed years later by a new primary DCIS diagnosis.Together, Laura and Dr. Peled unpack what patients are rarely told about DCIS (stage zero breast cancer), the difference between recurrence and a second primary cancer, and how advances in surgery are transforming survivorship—including sensation-preserving mastectomy.This conversation bridges clinical expertise and lived experience, offering clarity, compassion, and permission to choose the path that aligns with your body and values.In this episode: What DCIS really is—and why “stage zero” can be misleadingRecurrence vs. second primary breast cancer: why biology mattersLumpectomy vs. mastectomy and why survival outcomes are often the sameHow guilt and self-blame show up after a second diagnosisBeing diagnosed with breast cancer as a physicianNavigating treatment when your colleagues are your caregiversThe evolution of oncoplastic surgery and patient-centered careWhy loss of breast sensation is under-discussed—but life-changingHow sensation-preserving mastectomy worksWhat questions to ask your surgeon about sensation, nerves, and recoveryMaking decisions based on your priorities—not fear or pressureAbout today's guestDr. Anne Peled is a board-certified plastic, reconstructive, and breast surgeon in private practice in San Francisco and Co-Director of the Sutter Health California Pacific Medical Center Breast Cancer Center of Excellence. Trained at Amherst College, Harvard Medical School, and UCSF, Dr. Peled completed a unique fellowship combining breast oncologic surgery and reconstruction.Her clinical and research work focuses on oncoplastic surgery, preserving and restoring sensation after mastectomy, improving patient outcomes, and breast cancer risk reduction. She is also a breast cancer survivor herself, bringing rare dual insight to patient care. Support the showLatest News: Become a Breast Cancer Conversations+ Member! Sign Up Now. Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources! Enjoying our content? Please consider supporting our work.

In this solo episode of Keeping Abreast, Dr. Jenn Simmons answers the exact questions women ask her every day about breast cancer risk, hormone therapy, aromatase inhibitors, and screening. She breaks down the difference between bioidentical and non-bioidentical hormones, what “high risk” actually means, why fear-based medicine keeps women stuck, and how to build a screening and prevention plan you understand and trust. If you've felt dismissed, confused, or pressured into one-size-fits-all choices, this episode gives you language, clarity, and next steps to advocate for your body.In This Episode, You'll Learn:Bioidentical vs non-bioidentical hormones, and what matters after breast cancerThe truth about estrogen, recurrence risk, and the “have vs had breast cancer” distinctionWhy aromatase inhibitors feel brutal, what they're doing, and how to support your body on themWhat “high risk” really means, plus how breast density actually fits into riskSafer screening options like QT and ultrasound, and what to do when QT isn't availableHow the ARIA tear test works, what a positive result means, and your next stepsWhat calcifications can signal and how to think about DCIS without panicHow to combine integrative care with conventional oncology without losing supportWhy breast cancer is tied to inflammation and metabolic health, and what to trackEpisode Timeline:00:00 Introduction and Purpose of the Episode 03:05 Why Women Aren't Getting Clear Answers About Breast Health 06:00 Bioidentical vs Non-Bioidentical Hormones 13:30 Estrogen, Hormone Therapy, and Breast Cancer Risk 20:10 Aromatase Inhibitors Explained 27:45 Supporting Quality of Life While on Aromatase Inhibitors 34:30 Understanding What “High Risk” Really Means 39:40 Breast Density Explained 45:30 Limitations of Mammograms and MRI 50:40 The ARIA Tear Test and Prevention-Based Screening 56:30 QT Scan, Ultrasound, and Safer Imaging Options 1:02:40 Screening After Breast Cancer Treatment 1:07:50 Breast Calcifications and DCIS 1:11:00 Integrative Care and Root Cause Healing 1:13:00 Closing Thoughts and Where to Find SupportTo talk to a member of Dr. Jenn's team and learn more about working privately with RHMD, visit: https://jennsimmons.simplero.com/page/377266?kuid=327aca17-5135-44cf-9210-c0b77a56e26d&kref=vOKy0sAiorrKTo get your copy of Dr. Jenn's book, The Smart Woman's Guide to Breast Cancer, visit: https://tinyurl.com/SmartWomansBreastCancerGuideTo purchase the auria breast cancer screening test go here https://auria.care/ and use the code DRJENN20 for 20% Off.Connect with Dr. Jenn:Website: https://www.jennsimmonsmd.com/Facebook: https://www.facebook.com/DrJennSimmonsInstagram: https://www.instagram.com/drjennsimmons/YouTube: https://www.youtube.com/@dr.jennsimmons

Love the episode? Send us a text!What does it really mean to be diagnosed with DCIS (ductal carcinoma in situ)—often called “stage zero” breast cancer?In this in-depth episode of Breast Cancer Conversations, host Laura Carfang is joined by a breast surgical oncologist, a radiation oncologist, and a patient advocate to unpack why DCIS can be both reassuring and deeply complex. While survival rates are excellent, treatment decisions often involve difficult trade-offs between reducing recurrence risk and preserving long-term quality of life.The panel explores how advances in tumor biology, radiation techniques, and genomic testing—particularly the DecisionRT test—are helping clinicians and patients personalize care. Together, they discuss when radiation may meaningfully reduce recurrence risk, when it may be safely avoided, and how shared decision-making empowers patients to choose treatment paths based on information rather than fear.Guests:Dr. Erica Giblin, a breast surgical oncologist in Indianapolis and Director of Breast Surgical Oncology at Ascension, who brings a surgeon's perspective on balancing effective treatment with long-term survivorship.Dr. Fleure Gallant, a nationally recognized leader in breast radiation oncology and Radiation Medicine Lead for the Breast Disease Management Team at Northwell Health Cancer Institute, whose work focuses on delivering highly personalized, quality-of-life-centered care.And Dr. Leona Hamrick, Vice President of Global Medical Affairs at PreludeDx, a board-certified physician associate with decades of experience in internal medicine and oncology diagnostics—and an 11-year stage III breast cancer survivor who brings the patient voice into every scientific conversation.Topics Discussed:What DCIS is—and why it's considered non-invasive breast cancerWhy DCIS is classified as stage zero, regardless of sizeHow DCIS differs from invasive breast cancer and LCISWhy a DCIS diagnosis can still be emotionally traumaticStandard treatment approaches: lumpectomy, mastectomy, radiation, and hormone therapyWhen and why radiation therapy is recommended after DCISHow radiation schedules have evolved (5 days vs. 3–6 weeks)What DecisionRT measures and how it helps predict recurrence riskWhy tumor biology matters more than age aloneShared decision-making vs. fear-based decision-makingQuality-of-life considerations, especially for younger patientsWhy more options can sometimes feel more overwheUnderstanding Hypophosphatemia: Recognition, Diagnosis, and TreatmentEndocrine experts distinguish Hypophosphatemia from osteoporosis & osteomalaciaListen on: Apple Podcasts SpotifySupport the showLatest News: Become a Breast Cancer Conversations+ Member! Sign Up Now. Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources! Enjoying our content? Please consider supporting our work.

The FDA told him no in 1992. They said giving estrogen to breast cancer survivors would put women at "unacceptable risk." He did the study anyway.Dr. Avrum Bluming is a medical oncologist, emeritus clinical professor of medicine at USC, former senior investigator for the National Cancer Institute, and co-author of Estrogen Matters. He's been fighting estrogen fear for over 30 years long before it was safe or popular to do so.His origin story starts with his wife. At 45, she developed breast cancer. The chemotherapy he gave her threw her into premature menopause. She couldn't sleep. She had hot flashes, night sweats, painful urination, palpitations. She couldn't remember what she'd read two pages back. And he an oncologist who had induced menopause in countless breast cancer patients—had been sympathetic but didn't know how to help them until he saw what was happening with his wife.So he started a study in 1992 to give estrogen to breast cancer survivors. The FDA denied him twice. He did it anyway. By 1997, he presented his data to 8,500 oncologists from around the world. The National Cancer Institute said it was "irresponsible" to study this. The audience challenged them. Dr. Bluming's data showed no increased risk of recurrence.We talk about the Women's Health Initiative, how the media misinterpreted the data, why the estrogen alone actually decreased breast cancer by 23% and breast cancer death by 40%, and why the box warning that just came off in November 2025 never should have been there in the first place. There are now 26 studies in the English literature on giving estrogen to breast cancer survivors. Only one showed increased risk. Four showed decreased risk. Twenty-five showed no difference.Highlights:The FDA denial story: "Don't shoot me, I'm just the messenger".Why tamoxifen works better in premenopausal women (even though it raises estrogen 4-5x).The DCIS patient whose oncologist changed their tune after the box warning came off.The FDA committee member who asked "most of your patients are going to die anyway, aren't they?"showing how little some understood about breast cancer survival.When he asked if the FDA actually read his research before denying it: "Don't shoot me, I'm just the messenger"—a quote that reveals everything.What actually causes breast cancer (spoiler: nobody knows).If you've been denied estrogen or hormone therapy, share this episode with your provider. Share Estrogen Matters with its 555 references. Share the data. At this point, there's overwhelming evidence showing HRT is safe and beneficial for most women. But some clinicians are still using outdated information from 2002. You deserve care based on current science, not decades-old fear.Get in Touch with Dr. Bluming:WebsiteInstagramStudyGet in Touch with Me: WebsiteInstagramYoutubeSubstackMentioned in this episode:GSM CollectiveThe GSM Collective - Chicago Boutique concierge gynecology practice Led by Dr. Sameena Rahman, specialist in sexual medicine & menopause Unrushed appointments in a...

We share Nancie Steinberg's path from losing her mother to breast cancer to navigating her own diagnosis, CML management, and a new DCIS finding, translating hard-won lessons into everyday advocacy. Practical guidance on second opinions, seeing a breast surgeon, and building support grounds the whole conversation.• Why a missed chemo recommendation changed how we view second opinions• How to interview oncologists and assess fit• Grief, work, and parenting through treatment• Opening up about chronic myeloid leukemia after years of silence• Advocacy that moves policy on screening and access• Why to see a breast surgeon rather than rely only on OB-GYN exams• MRI, mammogram and ultrasound roles for high-risk monitoring• DCIS decisions, reconstruction options, and recovery planning• Finding therapy, community, and momentum for better days Are you loving the Test Those Breasts! Podcast? You can show your support by donating to the Test Those Breasts Nonprofit @ https://testthosebreasts.org/donate/Where to find Jamie:Instagram LinkedIn TikTok Test Those Breasts Facebook Group LinkTreeJamie Vaughn in the News!Thanks for listening!I would appreciate your rating and review where you listen to podcasts!I am not a doctor and not all information in this podcast comes from qualified healthcare providers, therefore may not constitute medical advice. For personalized medical advice, you should reach out to one of the qualified healthcare providers interviewed on this podcast and/or seek medical advice from your own providers .

Today's guest is Jennifer Douglas, breast cancer survivor, author, and national recognized patient advocate. Surviving DCIS (Ductal Carcinoma In Situ), she felt called to encourage others through her writing and online advocacy.We talk all about DCIS (what it is and isn't, treatments and challenges), the journey of writing a book and why she felt called, the importance of trust in your medical team, emotional well being, and so much more!There are many misconceptions out there about DCIS and hopefully this episode helps to bring some clarity to this type of breast cancer.Resources:A Breast Cancer Journey: Living It One Step at a Time: Info https://jenniferadouglas.com/books/Amazon: https://www.amazon.com/author/mmejendouglasEncourage: Breast Cancer and Beyond Course:https://www.pearlsofencouragement.com/join-encourage-membershipBlog and Author Site: jenniferadouglas.comAdvocacy and Course: pearlsofencouragement.comJennifer's Instagram: https://www.instagram.com/mmejendouglasJennifer's Facebook: https://www.facebook.com/mmejendouglasJennifer's X: https://x.com/mmejendouglasJennifer's Linkedin: https://www.linkedin.com/in/mmejendouglas/Follow:Follow me: https://www.instagram.com/melissagrosboll/My website: https://melissagrosboll.comEmail me: drmelissagrosboll@gmail.com

As a nurse practitioner, I feel a deep responsibility to my listeners and community to ensure that every guest I bring on shares accurate, evidence-based information. A few months ago, I decided to remove two podcasts from earlier this year to make way for an expert who could speak specifically and authoritatively on breast cancer health. So, I am honored to welcome Dr. Robin Roth today, better known as The Boobie Docs, on her popular breast health social media platform, where she shares information about breast cancer in a fun and educational way.  Dr. Roth is an associate professor of radiology, specializing in breast and abdominal imaging. She is also the host of The Girlfriend's Guide to Breast Cancer podcast, created to support those navigating a breast cancer diagnosis or caring for a loved one. In our discussion today, we dive into misinformation about breast health and breast imaging. We explore the importance of acknowledging disinformation on social media, risk factors for early breast cancer screening, significant and modifiable risk factors, and the effects of dense breast tissue. We examine breast imaging, exploring ultrasound and mammography, the differences between 2D and 3D mammograms (the gold standard), and when to use MRIs. We clarify why thermography and QT imaging are not the gold standard, and why we need to request different types of imaging modalities. We discuss the importance of screenings, challenges, including diagnoses like DCIS, personalized approaches to breast cancer screening, breast cancer staging, and issues with imaging after mastectomies and with implant placement. Dr. Roth also explains how 80% of breast biopsies end up being benign, how to manage anxiety and callbacks for mammograms, how to understand lab reports in plain language terms, and the benefits of supportive resources like cancerbesties.com. With her expertise and approachable style, Dr. Roth reminds us that proper information can make all the difference when it comes to breast health. You will not want to miss this conversation, especially during Breast Cancer Awareness Month. IN THIS EPISODE, YOU WILL LEARN: How online platforms fuel confusion around breast health and imaging Disinformation may influence breast cancer screening decisions Modifiable factors that can reduce or increase your risk of breast cancer Why dense breast tissue matters for imaging accuracy Ultrasounds, 2D and 3D mammograms, and MRIs  Thermography and QT imaging are not gold standards Why every individual DCIS diagnosis needs a personalized approach Breast cancer staging and how it guides treatment 80% of biopsies are benign, but still essential How to manage anxiety around callbacks and make sense of lab reports Connect with Cynthia Thurlow   Follow on X Instagram LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Connect with Dr. Robyn Roth On her website Social Media: @the boobie docs Preorder a copy of Everyone Has Boobies

When the scariest thing happens and you get through it, you realize that you're stronger than you ever thought you could be. -Jenna McCarthy Making that appointment to schedule her first mammogram was on Jenna McCarthy's mind for a while. At 41, she just wanted to get it over with and “check that box.” What she didn't expect was what happened next. In this up-close and personal interview, Jenna shares her diagnosis with DCIS, or ductal carcinoma in situ, an early-stage breast cancer. The mother of 4-year-old twin boys and a 9-year-old daughter, Jenna was more concerned about their state of mind than her own. Surrounded by a large and supportive extended family, she had a double mastectomy and implants just 3 months ago and is now cancer-free. In this interview, Jenna gives thanks to the Ellie Fund elliefund.org, a local non-profit devoted to supporting breast cancer patients by funding care and providing hope. Determined to spread the word about early detection, Jenna says, “Schedule your mammogram today. What if I had waited another year? If there were some way to know that a person hearing my story went out and got her mammogram, I would heal so much.” #breastcancerawareness #mammogram #thestorybehindhersuccess wife, mother & breast cancer survivor elliefund.org

In this powerful and thought-provoking episode of "Not Your Mother's Menopause," host Dr. Fiona Lovely welcomes back integrative oncologist and breast surgeon Dr. Jenn Simmons for their annual conversation. As we enter Breast Health Awareness Month, Dr. Simmons presents a compelling critique of the current screening paradigm, challenging long-held beliefs about mammograms. She delves into the concerning issue of over-diagnosis, explaining how finding and treating certain conditions, like DCIS, may not correlate with saving lives and can instead lead to unnecessary treatments with significant side effects. The discussion offers a hopeful path forward, focusing on true prevention and empowering women with knowledge. Dr. Simmons introduces innovative, less invasive screening options and emphasizes the foundational principle that breast health is overall health. She also tackles the controversial topic of hormone replacement therapy after a breast cancer diagnosis, sharing her clinical perspective on its safety and importance for quality of life.  This episode is an essential listen for any woman seeking to make truly informed decisions about her health, advocating for a more logical, personalized, and proactive approach to breast care.  You can find out more about Dr Jenn Simmons here. Thank you to our sponsors for this episode:

In this powerful episode of Keeping Abreast, Dr. Jenn Simmons welcomes advocate Donna Pinto to uncover the truth about DCIS (ductal carcinoma in situ), mammography, and the epidemic of overdiagnosis.Donna shares her personal journey from shock diagnosis to advocacy, exposing how fear, language, and profit drive women into unnecessary treatments. Together, she and Dr. Jenn highlight the emotional toll of mislabeling DCIS as cancer, the shortcomings of mammograms, and the need for safer, smarter approaches.

A routine mammogram set off a chain of decisions Erin Hagen never expected to make at 40. What the radiology report called DCIS felt both urgent and confusing, and the days that followed were a blur of consults, terminology and timelines. We sit down with Erin and Dr. Christina Canzoneri from Centra's plastic and reconstructive surgery team to unpack how you move from a diagnosis to a plan you can live with.We walk through choosing a bilateral mastectomy, weighing immediate versus delayed reconstruction and confronting the fear of anesthesia and drains more than the incisions themselves. Dr. Canzoneri breaks down what breast reconstruction really involves, tissue expanders, fills, implants, healing windows, and addresses the biggest misconceptions, including insurance coverage that's federally required after mastectomy, symmetry procedures on the other breast, and why “elective” doesn't mean “cosmetic.” Erin shares the practical wins that eased the hardest days: a nurse navigator who translated options, local appointments five minutes from home, and a surgical team that showed up with skill and small kindnesses, even holding her hand as the anesthesia set in.If you're navigating DCIS, early breast cancer, or simply deciding when to book your first mammogram, this conversation offers clear guidance and grounded hope. You'll hear how to ask better questions, what to expect from recovery, how follow-ups with expanders work and how to coordinate care across surgery, oncology, radiation, genetics and imaging. Most of all, you'll hear why proximity, transparency and trust can transform a scary season into a path back to normal life. For more content from Centra Health check us out on the following channels.YouTubeFacebookInstagramTwitter

ปฏิรูปวงการสาธารณสุขเมื่อพยาบาลในออสเตรเลียจะสามารถสั่งยาแทนแพทย์ได้ เมยา คาร์ทไรท์ หญิงไทยในเมลเบิร์น ผู้เคยตรวจพบมะเร็งเต้านมระยะศูนย์ (Stage 0 – DCIS) เมื่อ 3 ปีก่อน เล่าประสบการณ์ของเธอในการตรวจพบและรักษามะเร็งระยะเริ่มต้น

เมยา คาร์ทไรท์ หญิงไทยในเมลเบิร์น ผู้เคยตรวจพบมะเร็งเต้านมระยะศูนย์ (Stage 0 – DCIS) เมื่อ 3 ปีก่อน เล่าประสบการณ์ของเธอในการตรวจพบและรักษามะเร็งระยะเริ่มต้น

In this episode, we sit down with Lorri Pimentel of Santa Rosa, California, a resilient survivor who shares her deeply personal journey through breast cancer, acute myeloid leukemia (AML), and a life-saving bone marrow transplant. We explore not only the medical milestones but also the practical and emotional realities of navigating treatment and recovery, especially in the context of caregiving during the COVID-19 pandemic.Lorri opens by walking us through her diagnosis timeline: first with DCIS breast cancer in 2016, followed by an AML diagnosis in 2019. She underwent intense chemotherapy and, after a relapse, received a stem cell transplant in March 2021. Her story is not only one of medical complexity but also of personal upheaval—she was in the middle of a divorce and raising three children, with limited family caregiving options. Her caregivers were her friends and former work colleagues, who rotated week by week to support her recovery.We dive into Lorri's insights and hard-earned lessons about caregiving and post-transplant life. She stresses the importance of flexibility in caregiver scheduling, being prepared for early hospital discharge, and having a list of essential medical contacts readily available. She advises caregivers to undergo thorough training, keep detailed records for outpatient visits, and maintain strict medication management practices.Lorri doesn't shy away from sharing her missteps. She discusses her experience with Graft-versus-Host Disease (GvHD), the dangers of sun exposure, and complications like mucositis and insomnia. Her tips—like using a water pick, prescription mouthwash, fluoride toothpaste, and avoiding self-medicating with cannabis—are based on lived experience. She also shares less obvious insights, such as the need for UV-protective clothing, avoiding rice leftovers, and managing dry eyes with serum-based drops not yet FDA-approved.Transportation and social isolation were also major themes. Lorri emphasizes the importance of arranging reliable rides to appointments and finding indoor outlets for creativity and community. She found healing in watercolor art, music, yoga, and support groups. Her volunteer work with LLS, now Blood Cancer United, and NMDP reflects her dedication to mentoring others on the same path.We wrap up by discussing Lorri's present-day life. Now more than four years post-transplant, she's active, creative, and grounded in gratitude. Her final message is one of hope and purpose: bone marrow transplant recovery is slow, but it's life-changing, and each day is a gift worth sharing.This season is sponsored by Sanofi: https://www.sanofi.com/And Jazz Pharmaceuticals: https://www.jazzpharma.com/ National Bone Marrow Transplant Link - (800) LINK-BMT, or (800) 546-5268.nbmtLINK Website: https://www.nbmtlink.org/nbmtLINK Facebook Page: https://www.facebook.com/nbmtLINKFollow the nbmtLINK on Instagram! https://www.instagram.com/nbmtlink/The nbmtLINK YouTube Page can be found by clicking here.To participate in the GVHD Mosaic, click here: https://amp.livemosaics.com/gvhd Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

A medical assistant at Elizabeth Wende Breast Care in Upstate New York, Chelsea Vangrol had seen young women diagnosed with breast cancer. But she never expected to be one of them. She shares her experience of being diagnosed with DCIS at age 25 so other people in a similar situation will know they're not alone.Listen to the episode to hear Chelsea discuss: strategies she used to cope with stress and fear the factors she considered when making treatment decisions what she'd like other people who are diagnosed with breast cancer in their 20s to know

Ductal carcinoma in situ (DCIS) represents a clinical crossroads in breast surgery—balancing the risks of over-treatment with the need to prevent invasive cancer. With new data from active monitoring trials, the pressure is on for surgeons to personalize care. Tune in to this essential episode to stay ahead of the curve on DCIS management and to hear expert insights from two leading breast surgical oncologists. Hosts: - Rashmi Kumar, MD, PhD Resident, University of Michigan General Surgery Residency Program Twitter/X: @RashmiJKumar - Melissa Pilewskie, MD Attending Breast Surgical Oncologist, Co-Director of the Weiser Family Center for Breast Cancer, Michigan Medicine Twitter/X: @MPilewskie -  Stephanie Downs-Canner, MD Attending Breast Surgical Oncologist & Physician-Scientist, Memorial Sloan Kettering Cancer Center, Program Director of the Breast Surgical Oncology Fellowship Training Program Twitter/X: @SDownsCanner Learning Objectives: - Define DCIS and explain its significance as a precursor to invasive breast cancer. - Discuss challenges in diagnosing and risk-stratifying DCIS. - Review current standards for surgical and adjuvant management of DCIS. - Understand the implications of new research, including the COMET trial, for low-risk DCIS. - Evaluate patient-centered strategies for managing DCIS and preventing over-treatment. References: - Worni M, Akushevich I, Greenup R, et al. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ. J Natl Cancer Inst. 2015;107(12):djv263. PubMed - Francis A, Thomas J, Fallowfield L, et al. Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer. 2015 Jan;51(16):2296-303. PubMed - Elshof LE, Tryfonidis K, Slaets L, et al. Feasibility of a non-surgical management strategy for low-grade DCIS: The LORD study. Eur J Cancer. 2015;51(12):1497–1510. PubMed - Toss MS, et al. Ductal carcinoma in situ (DCIS): current management and future directions. Cancer Treat Rev. 2020;90:102091. PubMed - Comparative Effectiveness of Surgery versus Active Monitoring for Low-Risk DCIS (COMET) Trial Results. Early COMET Results: King TA, et al. Surgical excision versus active monitoring for low-risk ductal carcinoma in situ (DCIS): 2-year results of the COMET randomized trial. J Clin Oncol. 2024; e2400110. PubMed Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

In this episode of Keeping Abreast, Dr. Jenn Simmons welcomes Dr. Hania Bednarski, a breast surgeon pioneering cryoablation as an alternative to conventional breast cancer surgery.For decades, breast cancer treatment has changed little—yet Dr. Bednarski is forging a new path, reducing trauma while preserving women's wholeness. She shares her journey from trauma and hand surgery into breast care, and ultimately into cryoablation. Together, she and Dr. Jenn explore why this approach matters, how it's performed, and what it means for the future of breast cancer care.The conversation challenges assumptions about mammograms, chemotherapy, lymph node surgery, and hormones. Both physicians stress the importance of autonomy, personalized treatment, and a future where patient choice—not rigid protocols—guides care.This episode is essential for women navigating breast health, practitioners curious about new frontiers, and anyone passionate about transforming medicine from invasive to empowering.In This Episode, You Will Learn:How Dr. Bednarski's career led her to cryoablationWhy conventional surgery can cause lasting traumaWhat cryoablation is, how it works, and who it helpsWhy informed consent and patient choice matterThe pitfalls of mammograms and over-diagnosisHow cryoablation may engage the immune systemWhy lymph node surgery is diagnostic—not curativeThe truth about estrogen and breast cancer riskHow financial incentives block innovation

In the conclusion of this two-part conversation, Dr. Jenn Simmons and Dr. Jeffrey Dach go deeper on bioidentical hormones, long-term estrogen deprivation (LTED), and why “have” vs. “had” breast cancer matters when discussing HRT. They examine apoptosis after LTED, the role of estrogen in genomic stability, and how overdiagnosis from screening can drive unnecessary treatment. They also cover practical prevention pillars—iodine, DIM, selenium, and vitamin D—and what thoughtful, individualized care can look like for women navigating menopause and survivorship.In This Episode, You Will Learn:How reintroducing estrogen can trigger apoptosis in specific contextsWhy “have” vs. “had” breast cancer changes the HRT conversationHow screening, overdiagnosis, and rising mastectomy rates intersectThe difference between natural progesterone and synthetic progestinsHow iodine, DIM, selenium, and vitamin D factor into prevention programsWhat estrogen metabolites (2-hydroxy vs 4-hydroxy) and COMT mean for riskWhere integrative oncology and repurposed therapies fit into patient-centered careEpisode Timeline Highlights00:00:51 LTED explained: estrogen reintroduction & apoptosis 00:06:48 How long is “long-term” deprivation? What the studies suggest 00:10:29 “Have” vs. “had” breast cancer—why words matter for HRT decisions 00:12:48 Integrative oncology, repurposed drugs & fasting in cancer care context 00:17:41 Who may be a candidate for HRT after curative treatment? 00:20:11 Autopsy data, DCIS, and the problem of overdiagnosis 00:27:10 Why finding smaller tumors doesn't always change overall survival 00:29:29 The unintended rise in mastectomy rates with screening 00:47:33 Is it ever too late for HRT? Benefits into the 60s and 70s 00:50:02 Osteoarthritis, sleep, mood—systemic effects of estrogen deficiency 00:54:15 Metabolites & methylation (COMT) 00:58:22 Prevention stack: iodine, DIM, resveratrol, NAC 00:59:31 Selenium's role & vitamin D optimization 01:03:04 Risk-reduction strategies & individualized care 01:10:40 Closing reflections & resources

Listen up ladies. Talking boobs, vagina's and health advocacy.My beloved client sent me down a rabbit hole, and it's worthy for ALL WOMEN TO HEAR. Let's get some facts straight about how women are treated by today's medical system. I've spent 22 years in the wellness industry and spen a great amount of time studying functional medicine and have worked closely with women—especially post–breast cancer clients—to restore their health and well-being. While the points below draw on observations from a recent interview I watched, they highlight critical issues in hormone therapy, cancer care, and the loss of sacred body knowledge.Uncensored Truths What the Medical System Isn't Telling WomenAs a salon and spa owner and a passionate advocate for women's health, I've seen firsthand how the medical system often fails women, especially when it comes to hormones and cancer treatment. It's time to get some facts straight.Bioidentical Hormones vs. Synthetics: The Key DifferenceI can tell you that bioidentical hormones—specifically estrogen—saved my life and my sleep. A common misconception is that synthetic hormones are the same, but they are absolutely not. Bioidentical hormones are designed with the exact same molecular structure as those naturally produced by your body. Synthetic hormones, on the other hand, are chemically altered. To put it simply, your body's cell receptors can "read" bioidentical hormones clearly, but they struggle to recognize and process the fuzzy "writing" of synthetics.This distinction is crucial, particularly when we look at the well-known 2002 Women's Health Initiative study. This study linked traditional hormone therapy to health risks, but later research clarified that those risks were tied specifically to the synthetic progestin used, not the estrogen itself.The Shocking Facts of Women's Healthcare + DismissalThe medical industry's approach to women's health is often misguided, leading to unnecessary suffering. Here are some examples shared on a recent interview: * Vaginal Estrogen for Cancer Survivors: It's outrageous that some cancer centers still deny women access to vaginal estrogen, even when major medical societies have stated it's safe for everyone, including breast cancer survivors. This small step could prevent immense pain, urinary tract infections, and bladder issues.* A Focus on Appearance, Not Function: We spend a "s**t ton" of time and money on treatments like cold capping to save hair during chemotherapy, but we don't prioritize treating debilitating symptoms like vaginal atrophy and sexual dysfunction. Why aren't simple, effective solutions like vaginal estrogen a standard "pre-medication"?* The Divorce Rate After Cancer: An oncology nurse once told me about the high number of divorces after breast cancer treatment. This is not just a coincidence; it's a consequence of the physical and emotional toll—the shift from lover to caretaker, the pain from castration medications, and the loss of intimacy.* Profit Over Patients: The harsh reality is that breast cancer treatment is incredibly profitable. When women develop new medical problems from their treatment, they often become long-term customers, needing multiple pharmaceuticals to manage their side effects. This creates a system that prioritizes profit over a patient's long-term well-being and quality of life.IT IS SPIRITUAL. Reclaiming Our Bodies and Sacred KnowledgeAt one point in history, the female body was viewed as sacred. Rites like menstruation, childbirth, and healing were honored rituals. This was replaced by a sterile, clinical system. Midwives were criminalized, women with natural knowledge were branded as witches, and institutions took over.* Birth moved to hospitals, becoming controlled and monitored.* Menstruation became something to hide.* Menopause was pathologized instead of celebrated as a new phase of life.The message became clear: "Your body is not yours to understand. We'll tell you what it means." It's time to reclaim our bodies, trust our intuition, and demand a healthcare system that honors and heals, rather than profits from our suffering.IN SHORT: The Profit-Driven Treatment Model * Women are convinced they've been "cured" even when they've only had DCIS (which isn't technically cancer)* Treatment creates a cascade of medical problems requiring 5-10 additional pharmaceuticals* The industry profits from creating long-term medical customers* High-risk women are now being preemptively put on aromatase inhibitorsMost revealing was this insight: "Breast cancer happens in states of estrogen deficiency, not excess. Those receptors upregulate as a survival mechanism... looking for their missing lifeline."From Sacred Knowledge to Medical ControlThe interview concluded with a powerful historical perspective on how medical institutions systematically replaced women's body wisdom:What Was Sacred:* Menstruation honored in ceremony* Birth attended by midwives and family* The body seen as teacher, not threat* Community-supported transitionsWhat Was Taken:* Midwives criminalized* Earth-based healers branded as witches* Birth moved to hospitals - controlled, monitored, medicated* Menopause pathologized instead of honored* Women's body knowledge replaced with institutional controlThe Bottom LineThese interview insights reveal a healthcare system that often prioritizes profit over women's wellbeing, denies established safe treatments, and has systematically dismantled women's autonomy over their own bodies.Women deserve better than being told their suffering is necessary, their hormones are dangerous, and their body wisdom is irrelevant. It's time to question who benefits from keeping women in the dark about their own health - and demand change.Would love to know your thoughts. Drop them below. It's serious ladies. Sending you all my love - be your own advocate, be curious and love yourself ruthlessly. No one else will - the level that you can. xo Blue skies, KassandraResource reference Get full access to The Light Between at thelightbetween.substack.com/subscribe

What does the future hold for breast cancer treatment? Dr. Raz is here to talk about microwaving and freezing cancers, how staging works, and the role of artificial intelligence in finding new therapies and risks. In this episode, you’ll hear: What cancer staging really means and why it matters New ways doctors might treat breast cancer with less invasive methods How AI could shape breast cancer care and risk assessment Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts. Key Questions Answered 1.What is cancer, and specifically, what is breast cancer? 2. What does 'staging' mean in breast cancer, and why does it matter? 3. How is the size of a breast tumor classified, and what does that imply for its stage? 4. What is DCIS and what does stage zero breast cancer mean? 5. What is the TNM staging system in breast cancer? 6. How do receptor statuses (ER, PR, HER2) affect breast cancer treatment and prognosis? 7. What questions should a patient ask their surgeon or oncologist about a breast cancer diagnosis? 8. What is targeted therapy in breast cancer, and how does it differ from traditional chemotherapy? 9. What advancements are emerging in breast cancer imaging and treatment? 10. How is AI (artificial intelligence) contributing to the future of breast cancer detection, risk assessment, and treatment? Timestamped Overview 00:00 Uncontrolled Cell Growth Explained 03:09 Understanding Breast Cancer Staging 08:20 Cancer Staging: Impact of Receptors 12:33 Gene Editing Targets Cancer Cells 16:13 "Non-Surgical Cancer Targeted Therapy" 19:55 AI in Healthcare History Management 21:25 AI Quantifies and Accelerates ResearchSee omnystudio.com/listener for privacy information.

Program notes:0:44 Reanimating hearts for transplant1:44 Allow heart to sit for two to four minutes2:34 Outcomes in DCIS without surgery3:34 Free of breast cancer six months after diagnosis4:34 Numbers who went on to develop invasive disease low5:34 May change how we approach DCIS6:09 Suicidality around the world in older adults7:09 Guns, pesticides, hanging8:10 Increase primary care diagnosis of OUD9:10 Three clinics in four U.S. states10:10 Six million adults with OUD11:10 Many physicians unaware of medicines12:43 End

Episode Summary: Breast Cancer Prevention Just Took Two Big Steps ForwardIn this short but powerful episode, Georgie breaks down two groundbreaking developments in breast cancer prevention that could reshape how we think about screening, menopause care, and early intervention:1️⃣ An FDA-authorized AI tool—Clairity Breast—that predicts a woman's five-year breast cancer risk from a standard mammogram, even when it appears normal.2️⃣ A menopause drug, Duavee, that may help prevent invasive breast cancer in women with a history of high-risk lesions like DCIS.These tools aren't just high-tech—they're practical, accessible, and represent a smarter, more equitable approach to women's health.Whether you're a clinician, policymaker, or woman navigating your own care, this episode breaks down what you need to know.

Women are generally told that if they have a breast cancer diagnosis, they should steer clear of estrogen. In this episode, I have a conversation with Dr. Swati Kulkarni, the lead investigator of a new study in which women with a newly diagnosed breast ductal carcinoma in situ, DCIS, were given a month's worth of hormone therapy before standard treatment to see the impact it would have on developing cancer cells.  What DCIS is and how it is typically diagnosed. If DCIS is considered to be a pre-cancer or a cancer If DCIS is untreated, how often it will progress to invasive cancer  If treated, how often women with DCIS go on to develop invasive cancer?  Why this particular form of hormone therapy, conjugated estrogens and bazodoxifene (Duovee™) was used in the study The details of the study The results of the study  The Promise Study: A presurgical randomized clinical trial of CE/BZA vs placebo in postmenopausal women with ductal carcinoma in situ. Link to Abstract My summary of the study on Substack https://drstreicher.substack.com/p/can-hormone-therapy-shrink-breast Link to Kagan episode on Duovee with Dr. Kagan Episode 124 All Hormones Are Not Created Equal with Dr. James Simon Dr. Streicher is on SUBSTACK      DrStreicher.Substack.com Articles Monthly newsletter All COME AGAIN podcast episodes Monthly News Flash Reports on recent research  Monthly Zoom Ask Me Anything Webinar  Information on Dr. Streicher's COME AGAIN Podcast- Sexuality and Orgasm https://drstreicher.substack.com/p/all-about-come-again Lauren Streicher MD, is a clinical professor of obstetrics and gynecology at Northwestern University's Feinberg School of Medicine, the founding medical director of the Northwestern Medicine Center for Sexual Medicine and Menopause, and a Senior Research Fellow of The Kinsey Institute, Indiana University. She is a certified menopause practitioner of The Menopause Society. She is the Medical Director of Community Education and Outreach for Midi Health.   Dr. Streicher is the medical correspondent for Chicago's top-rated news program, the WGN Morning News, and has been seen on The Today Show, Good Morning America, The Oprah Winfrey Show, CNN, NPR, Dr. Radio, Nightline, Fox and Friends, The Steve Harvey Show, CBS This Morning, ABC News Now, NBCNightlyNews,20/20, and World News Tonight. She is an expert source for many magazines and serves on the medical advisory board of The Kinsey Institute, Self Magazine, and Prevention Magazine. She writes a regular column for The Ethel by AARP and Prevention Magazine.    LINKS Subscribe To Dr. Streicher's Substack Information About the COME AGAIN Podcast Dr. Streicher's CV and additional bio information To Find a Menopause Clinician and Other Resources  Glossary Of Medical Terminology BOOKS by Lauren Streicher, MD  Slip Sliding Away: Turning Back the Clock on Your Vagina-A gynecologist's guide to eliminating post-menopause dryness and pain Hot Flash Hell: A Gynecologist's Guide to Turning Down the Heat Sex Rx- Hormones, Health, and Your Best Sex Ever The Essential Guide to Hysterectomy                                       Dr. Streicher's Inside Information podcast is for education and information and is not intended to replace medical advice from your personal healthcare clinician. Dr. Streicher disclaims liability for any medical outcomes that may occur because of applying methods suggested or discussed in this podcast.                                     

Ocean City is banning some tents and canopies on the beach. World Pride Parade is this weekend and DCis prepping for it. National Mall has 30k small flags representing people who suffer from migraine and headaches.  Make sure to also keep up to date with ALL our podcasts we do below that have new episodes every week:The Thought ShowerLet's Get WeirdCrisis on Infinite Podcasts

In this episode, host Dr. Reni Butler speaks with Dr. Kalina Slavkova, Dr. Ruya Kang, Dr. Despina Kontos, and Dr. Habib Rahbar about their groundbreaking research using MRI-based radiomic features to improve risk stratification in ductal carcinoma in situ (DCIS). The discussion explores how combining clinical data, imaging, and AI-driven analysis could help personalize treatment and reduce overtreatment in breast cancer care. MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial). Slavkova and Kang et al. Radiology 2025; 315(1):e241628.

In this episode of The Cybersecurity Defenders Podcast, we discuss some intel being shared in the LimaCharlie community.Two significant crypto security breaches occurred in close succession this month, affecting both decentralized and centralized platforms. On May 22, Cetus—a decentralized exchange built on the Sui Network—was exploited via a vulnerability in its automated market maker (AMM). Meanwhile, Coinbase confirmed what it called a “targeted insider threat operation” that compromised data from less than 1% of its active monthly users.A threat group identified as “Hazy Hawk” has been systematically hijacking cloud-based DNS resources tied to well-known organizations, including the US Centers for Disease Control and Prevention (CDC), since December 2023. A newly disclosed vulnerability in Windows Server 2025, dubbed BadSuccessor, has raised major concerns among enterprise administrators managing Active Directory environments.Federal and international law enforcement, alongside a significant number of private-sector partners, have successfully dismantled the Danabot botnet in a multiyear operation aimed at neutralizing one of the more advanced malware-as-a-service (MaaS) platforms tied to Russian cybercriminal activity.

In our Patient from Hell Podcast Club episode, Ashley Dedman, vice president of mission delivery at Living Beyond Breast Cancer. They discuss the importance of patient advocacy, particularly in the context of breast cancer and DCIS (ductal carcinoma in situ). Ashley shares her personal journey with cancer as a caregiver and advocate, emphasizing the need for timely information and emotional support for patients and their families. The conversation highlights the evolving landscape of cancer treatment, the significance of understanding individual experiences, and the critical role of mental health in navigating cancer journeys.Chapters00:00 Introduction to Patient Advocacy and Podcast Goals03:03 Understanding DCIS: A Deep Dive into Breast Cancer06:03 Personal Stories: The Impact of Cancer on Families12:06 The Role of Advocacy in Cancer Care17:51 Navigating Treatment Decisions and Patient Empowerment24:06 Mental Health and Support in Cancer JourneysConnect with Us:Enjoyed this episode? Make sure to subscribe, rate, and review! Follow us on Instagram, Facebook, or Linkedin @mantacares and visit our website at mantacares.com for more episodes and updates.Listen Elsewhere: Website: https://mantacares.com/pages/podcast?srsltid=AfmBOopEP5GJ-Wd2nL-HYAInrwerIVhyJw67salKT-r9Qb_gadBvbHie YouTube: https://youtu.be/2SxvTqJht34?si=2U_98RfJJeWkTaT3 Spotify: https://open.spotify.com/episode/3TR1lFLtf6em5YyKtlWy2L?si=6ma-9g_wTIWTCLmHiHF_Aw Apple: https://podcasts.apple.com/us/podcast/navigating-cervical-cancer-screening-surgery-and/id1622669098?i=1000706666920 Disclaimer:All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only. This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.This episode was supported by an award from the Patient-Centered Outcomes Research Institute.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Rachel Rubin is a board-certified urologist and one of the nation's foremost experts in sexual health. In this episode, she shares her deep expertise on the often-overlooked topic of women's sexual health, exploring why this area remains so neglected in traditional medicine and highlighting the critical differences in how men and women experience hormonal decline with age. Rachel explains the physiology of the menstrual cycle, the complex hormonal shifts of perimenopause, and the wide-reaching health risks associated with menopause, including osteoporosis, cardiovascular disease, dementia, and recurrent urinary tract infections. She also breaks down the controversy surrounding hormone replacement therapy (HRT), particularly the damaging legacy of the Women's Health Initiative study, and provides guidance on the safe and personalized use of estrogen, progesterone, and testosterone in women. With particular emphasis on local vaginal hormone therapy—a safe, effective, and underused treatment—Rachel offers insights that have the potential to transform quality of life for countless women. We discuss: Rachel's training in urology and passion for sexual medicine and women's health [3:00]; Hormonal changes during ovulation, perimenopause, and menopause: why they occur and how they impact women's health and quality of life [5:30]; Why women have such varied responses to the sharp drop in progesterone during the luteal phase and after menopause, and the differing responses to progesterone supplementation [14:45]; The physical and cognitive health risks for postmenopausal women who are not on hormone therapy [17:45]; The history of hormone replacement therapy (HRT), and how misinterpretation of the Women's Health Initiative study led to abandonment of HRT [20:15]; The medical system's failure to train doctors in hormone therapy after the WHI study and its lasting impact on menopause care [29:30]; The underappreciated role of testosterone in women's sexual health, and the systemic and regulatory barriers preventing its broader use in female healthcare [35:00]; The bias against HRT—how institutional resistance is preventing meaningful progress in women's health [46:30]; How the medical system's neglect of menopause care has opened the door for unregulated and potentially harmful hormone clinics to take advantage of underserved women [53:30]; The HRT playbook for women part 1: progesterone [57:15]; The HRT playbook for women part 2: estradiol [1:05:00]; Oral formulated estrogen for systemic administration: risks and benefits [1:13:15]; Topical and vaginal estrogen delivery options: benefits and limitations, and how to personalize treatment for each patient [1:17:15]; How to navigate hormone lab testing without getting misled [1:24:15]; The wide-ranging symptoms of menopause—joint pain, brain fog, mood issues, and more [1:31:45]; The evolution of medical terminology and the underrecognized importance of local estrogen therapy for urinary and vaginal health in menopausal women [1:37:45]; The benefits of vaginal estrogen (or DHEA) for preventing UTIs, improving sexual health, and more [1:41:00]; The use of DHEA and testosterone in treating hormone-sensitive genital tissues, and an explanation of what often causes women pain [1:50:15]; Is it too late to start HRT after menopause? [1:56:15]; Should women stop hormone therapy after 10 years? [1:58:15]; How to manage hormone therapy in women with BRCA mutations, DCIS (ductal carcinoma in situ), or a history of breast cancer [2:00:00]; How women can identify good menopause care providers and avoid harmful hormone therapy practices, and why menopause medicine is critical for both women and men [2:06:00]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

Are you about to get a mammogram and now worried about the conflicting information? Then tune into this episode with radiologist Dr. Robyn Roth who gives us her side of the story on mammograms and alternatives to breast screening.  You'll either love this episode or hate it, but I like to present both sides of the story. Over the last year I have had numerous guests who warned us of the dangers of mammograms. I had several of you reach out to me wanting me to share the other perspectives out there. So I gathered all the arguments that our guests have talked about in other episodes and presented them at Dr. Robyn to hear her rebuttal. We covered: The fears around mammograms Do mammograms really save lives? Are we over diagnosing and overtreating women? What is the damage that is done on a woman given a false diagnosis? What percentage of DCIS goes on to become an aggressive cancer from her experience? If mammograms don't pick up calcifications on dense breasts, why are we even doing them? What the man who invented mammograms says is the gold standard of breast screening Alternatives to mammograms and how reliable are they? If mammography is not recommended to pregnant women because of the risk of radiation on the fetus, then why are we all getting mammograms? Is a woman really a survivor if she dies at 6 years past her diagnosis instead of the time bias of 5?   Dr. Robyn Roth is an Ivy-league trained board-certified radiologist specializing in Breast and Abdominal Imaging, with over 15 years of clinical experience. She is better known as @TheBoobieDocs, her popular social media platform where she discusses breast cancer and breast health in an educational and fun way. She is a breast cancer specialist who educates, advocates and empowers about the importance of early breast cancer detection and understanding your risk factors. Dr. Roth hosts a podcast, “The Girlfriend's Guide to Breast Cancer, Breast Health, & Beyond” to help those navigating a breast cancer diagnosis.   RESOURCES https://pubmed.ncbi.nlm.nih.gov/21249649/ https://pmc.ncbi.nlm.nih.gov/articles/PMC7681269/ Contact Dr. Robyn Roth: Instagram @theboobiedocs https://www.instagram.com/theboobiedocs Podcast, the girlfriends guide to breast cancer https://podcasts.apple.com/us/podcast/the-boobie-docs-the-girlfriends-guide-to-breast/id1586884287  Website: https://theboobiedocs.com Email: theboobiedocs@gmail.com Instagram @theboobiedocs   Give thanks to our sponsors: Qualia senolytics and brain supplements. 15% off with code ZORA here. Try BEAM minerals at 20% off with code ZORA here.http://beamminerals.com/ZORA Get Primeadine spermidine by Oxford Healthspan. 15% discount with code ZORA ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Get Mitopure Urolithin A by Timeline. 10% discount with code ZORA at https://timeline.com/zora Get Magnesium Breakthrough by Bioptimizers. 10% discount with code HACKMYAGE at https://bioptimizers.com/hackmyage Try OneSkin skincare with code ZORA for 15% off https://shareasale.com/r.cfm?b=2685556&u=4476154&m=102446&urllink=&afftrack= Join ⁠⁠⁠Biohacking Menopause⁠⁠⁠ before May 1, 2025 to win a bottle of Accelerated Health iodine and Essential Amino Acids! 10% off with code ZORA at AcceleratedHealth.com   Join the Hack My Age community on: Facebook Page: ⁠⁠⁠⁠⁠@⁠Hack My Age⁠     Facebook Group: ⁠⁠⁠⁠⁠⁠@⁠Biohacking Menopause⁠⁠⁠⁠⁠⁠ ⁠  Private Women's Only Support Group: https://hackmyage.com/biohacking-menopause-membership/ Instagram: ⁠⁠⁠⁠⁠@⁠HackMyAge⁠    Website: ⁠⁠⁠⁠⁠⁠HackMyAge.com⁠   

Have you or someone you know been diagnosed with breast cancer and not sure how to advocate for yourself? Then you'll love this episode with integrative oncologist Dr. Jenn Simmons where she reveals some of the things that go behind closed doors in the breast cancer world. We cover: Different types of breast cancers What it means to have receptor positive or negative cancer BRCA mutations and breast cancer risk The business of medicine and how we fall into the system Statistics of DCIS being fatal How women are being harmed with diagnosis of DCIS What you can do if you get diagnosed with breast cancer Should you really take a watch and wait approach? How to move forward after surgery to restore health Can you take HRT when you have breast cancer? What to take instead of tamoxifen to lower recurrence? The risk of breast cancer when using birth control How to advocate for yourself for the best health outcome   Dr. Jenn Simmons is a controversial breast cancer surgeon turned integrative oncologist. You either like her or you don't, but she is redefining the landscape of breast cancer diagnosis, treatment, and prevention. Her approach combines: • Pioneering the use of bioidentical hormone replacement for breast cancer patients • A mission to eliminate over-imaging, over-biopsy, over-diagnosis, and over-treatment of breast cancer Dr. Jenn empowers women to reclaim their hormonal health and embrace a life worth living. Her innovative methods not only save lives but also preserve quality of life, offering hope and vitality to those facing breast cancer. Author of the bestselling book "The Smart Woman's Guide to Breast Cancer, which is a comprehensive guide giving expert insights and compassionate support to anyone faced with a breast cancer diagnosis   PAST EPISODES What Breast Cancer Surgeons Don't Tell You - https://hackmyage.com/what-breast-cancer-surgeons-dont-tell-you-dr-jenn-simmons/ Best Ways To Screen Breasts https://hackmyage.com/best-ways-to-screen-for-breast-cancer-steps-following-a-diagnosis-dr-jenn-simmons/ The Smart Woman's Guide to Breast Cancer:  https://tinyurl.com/SmartWomansBreastCancerGuide Podcast: Keeping Abreast with Dr. Jenn https://keepingabreastwithdrjenn.buzzsprout.com/ Safe, painless radiation free breast imaging: https://www.perfeqtionimaging.com/ Contact Dr. Jenn Simmons: Email: info@realhealthmd.comEmail: info@perfeqtionimaging.com Website: https://www.realhealthmd.com/ Instagram: https://www.instagram.com/drjennsimmons Facebook: https://www.facebook.com/drjennsimmons YouTube: https://www.youtube.com/@dr.jennsimmons5127 Give thanks to our sponsors: Qualia senolytics and brain supplements. 15% off with code ZORA here.  Try BEAM minerals at 20% off with code ZORA here. Get Primeadine spermidine by Oxford Healthspan. 15% discount with code ZORA ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.  Get Mitopure Urolithin A by Timeline. 10% discount with code ZORA at https://timeline.com/zora Get Magnesium Breakthrough by Bioptimizers. 10% discount with code HACKMYAGE at https://bioptimizers.com/hackmyage Try OneSkin skincare with code ZORA for 15% off https://shareasale.com/r.cfm?b=2685556&u=4476154&m=102446&urllink=&afftrack= Join ⁠⁠⁠Biohacking Menopause⁠⁠⁠ before April 1, 2025 to win OneSkin OS-01 peptide facial supplement and OS-01 eye cream! 15% off with code ZORA at OneSkin. Join the Hack My Age community on: Facebook Page: ⁠⁠⁠⁠⁠@⁠Hack My Age⁠     Facebook Group: ⁠⁠⁠⁠⁠⁠@⁠Biohacking Menopause⁠⁠⁠⁠⁠⁠ ⁠  Private Women's Only Support Group: https://hackmyage.com/biohacking-menopause-membership/ Instagram: ⁠⁠⁠⁠⁠@⁠HackMyAge⁠    Website: ⁠⁠⁠⁠⁠⁠HackMyAge.com⁠   

Love the episode? Send us a text!In this episode of Breast Cancer Conversations, I had the pleasure of speaking with Kathleen Moss, a nutritionist from Portland, Oregon, who shared her journey with breast cancer. Kathleen's story is both unique and insightful, as she was diagnosed with lobular breast cancer after a decade of screening and monitoring a shadow in her left breast. She detailed her experience with DCIS, the challenges of detecting lobular breast cancer, and the eventual discovery of invasive cancer following her mastectomy.Kathleen provided an in-depth explanation of lobular breast cancer, highlighting its distinct characteristics and the difficulties in detection due to its non-lump formation. She also discussed the importance of advocacy and education, emphasizing the need for awareness around different breast cancer subtypes.We delved into her surgical decisions, including her choice to forgo breast reconstruction in favor of a Goldilocks mastectomy, and the emotional and physical impacts of these choices. Kathleen's advocacy work with the Lobular Breast Cancer Alliance and her efforts to support and educate others through local advocacy teams were truly inspiring.Kathleen also shared her personal experiences with her mother's breast cancer diagnosis and passing, and how it shaped her perspective on life and death. As we wrapped up, she updated us on her current health status and the ongoing surveillance for potential recurrence.SURVIVINGBREASTCANCER.ORGAttend a free virtual SurvivingBreastCancer.org event:https://www.survivingbreastcancer.org/eventsFollow us on InstagramSurvivingBreastCancer.org: https://www.survivingbreastcancer.org/Breast Cancer Conversations: https://www.instagram.com/breastcancerconversations/About SurvivingBreastCancer.org: SurvivingBreastCancer.org, Inc. (SBC) is a federally recognized 501(c)(3) non-profit virtual platform headquartered in Boston with a national and global reach. Through education, community, and resources, SurvivingBreastCancer.org supports women and men going through breast cancer. We provide a sanctuary of strength, compassion, and empowerment, where those diagnosed with cancer unite to share their stories, learn invaluable coping strategies to manage wellness and mental health, and find solace in the unbreakable bond that fuels hope, resilience, and the courage to conquer adversity.Support the show

Join Kate, Mark, Gary and Henry as they discuss 4 new POEMs on treatment of sexual dysfunction, the benefits and harms of GLP-1 agonists, active surveillance vs usual care for ductal carcinoma in situ, and medications to prevent episodic migraine headache.

Today, I am honored to connect with my friend and colleague, Dr. Jenn Simmons. Dr. Simmons is an integrative oncologist, breast surgeon, author, podcast host, and the founder of Perfect Cutie Imaging.  In our discussion today, we dive into breast cancer statistics and the fact that most cases of breast cancer are preventable. We tackle the confusion caused by overdiagnosis, explain why mammograms can be problematic, and outline which breast cancer diagnoses are true emergencies. We provide clarity on the differences between various breast cancer types, the state of normal breast health, and how we have both estrogen and progesterone receptors. Dr. Simmons sheds light on DCIS (ductal carcinoma in situ) and explains why treatments like radiation may not always impact survival. We also examine the roles of trauma and alcohol in breast cancer risk, and we begin answering questions from listeners.  Don't miss this engaging, helpful, and proactive discussion with Dr. Jenn Simmons. We were wonderfully overwhelmed with all the questions we received, and with so much still to cover, I want to reassure everyone that we are already planning a follow-up AMA episode with Dr. Jenn. IN THIS EPISODE YOU WILL LEARN: The shift from reactive to proactive health and the need to build health rather than just treating diseases The role of lifestyle choices in reducing the risk of breast cancer Why mammograms are problematic, and how the incidence of breast cancer has increased in screened populations The carcinogenic effects of radiation The harmful effects of unnecessary breast cancer treatments The long-term effects of chemotherapy and radiation The different types of breast cancer The limitations of traditional cancer treatments and the importance of addressing the root causes of the disease How chronic stress and trauma can increase the risk of breast cancer. Why self-examining the breasts is essential Dr. Jenn introduces her clinician training program to equip providers with the knowledge to use alternative imaging Connect with Cynthia Thurlow   Follow on Twitter Instagram LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Connect with Dr. Jenn Simmons On her website Keeping Abreast with Dr. Jenn (podcast) On all social media: @Dr Jenn Simmons Dr. Jenn's new book, The Smart Woman's Guide to Breast Cancer, is available on Amazon.

Today, we dive into a thought-provoking discussion with Dr. Jennifer Simmons, a breast cancer surgeon turned functional medicine oncologist, who is redefining breast cancer diagnosis, treatment, and screening. Use Jenn's code: Drjenn20 for 20% of the Auria test.   What We Discuss: Critique of Mammograms and Below-Average Efficacy ... 03:15 Canadian Breast Cancer Screening Trial Findings ... 06:50 Concerns with Overdiagnosis in Mammograms ... 08:25 Consequences of Unnecessary Breast Cancer Treatments ... 11:40 Absence of Predictive Tests for Cancer Aggressiveness ... 15:10 Debunking the Myth of Early Detection's Efficacy ... 18:00 Dense Breast Tissue and Mammogram Limitations ... 21:30 Risks Associated with Mammogram Radiation ... 24:10 Importance of Lymphatic System Health ... 29:00 Alternative Approaches to Monitoring Breast Health ... 32:20 Holistic Benefits of Rebounding, Dry Skin Brushing ... 35:45 Criticism of Restrictive Bras and Advice on Usage ... 38:10 Bioidentical Hormone Replacement Therapy (HRT) Insights ... 41:20 Misconceptions About Estrogen and Breast Cancer ... 45:05 Introduction to the Mitolux Device ... 51:50 Dietary and Physical Recommendations for Optimal Health ... 54:20 History and Long-term Impact of Breast Health ... 1:09:05 Pharmaceutical Dependencies and Lifestyle Impact ... 1:12:20 Arguments Against Over-treatment of DCIS ... 1:15:30 Innovative Breast Cancer Screening Tests: AURIA and QT Scan ... 1:18:50 Challenges with Current Breast Cancer Treatments ... 1:22:10 Ethical Considerations in Breast Cancer Treatment ... 1:25:45   Made Possible By Our Amazing Sponsor: SiPhox - SiPhox Health offers at-home blood testing solutions, providing custom supplements based on your personalized blood work. Visit http://SiPhoxhealth.com/nat and use code LONGEVITY to save on your test.   Manukora - Looking to boost your immunity and gut health with nature's finest? Manukora Honey, sourced from New Zealand, brings you high-quality honey rich in health benefits. Visit this link http://manukora.pxf.io/kO0rJN to enjoy a special discount with the code LONGEVITY.   Wizard Sciences - Ready to upgrade your brain game? Unlock your cognitive potential with Neural Rx. Use code NAT15 at checkout to get 15% off your purchase. Don't wait—start the year with a sharper, more focused mind. Visit Wizardsciences.com   Nat's Links: YouTube Channel Join My Membership Community Sign up for My Newsletter  Instagram  Facebook Group